Temperament and character influence on depression treatment outcome

Anxiety and Depression

Moderating effect of comorbid anxiety disorders on treatment outcome in a randomized controlled psychotherapy trial in early-onset persistently depressed outpatients

Depress Anxiety.

Assmann N, Schramm E, Kriston L, Hautzinger M, Härter M, Schweiger U, Klein JP

doi: 10.1002/da.22839.

Anxiety and Depression

Symptom clusters in adolescent depression and differential response to treatment: a secondary analysis of the Treatment for Adolescents with Depression Study randomised trial

Lancet Psychiatry.

Bondar J, Caye A, Chekroud AM, Kieling C

doi: 10.1016/S2215-0366(20)30060-2.

EpilepsyAnxiety and Depression

Association of Depression and Treated Depression With Epilepsy and Seizure Outcomes: A Multicohort Analysis

JAMA Neurol.

Josephson CB, Lowerison M, Vallerand I, Sajobi TT, Patten S, Jette N, Wiebe S

doi: 10.1001/

Anxiety and Depression

Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression

J Psychiatr Res

Bartova L, Fugger G, Dold M, Swoboda MMM, Zohar J, Mendlewicz J, Souery D, Montgomery S, Fabbri C, Serretti A, Kasper S

doi: 10.1016/j.jpsychires.2021.06.028

RECOMMENDED

Anxiety and Depression

High occupational level is associated with poor response to the treatment of depression: A replication study

Eur Neuropsychopharmacol.

Mandelli L, Serretti A, Souery D, Mendlewicz J, Kasper S, Montgomery S, Zohar J

doi: 10.1016/j.euroneuro.

Anxiety and Depression

Influence of adjuvant detached mindfulness and stress management training compared to pharmacologic treatment in primiparae with postpartum depression

Arch Womens Ment Health.

Ahmadpanah M, Nazaribadie M, Aghaei E, Ghaleiha A, Bakhtiari A, Haghighi M, Bahmani DS, Akhondi A, Bajoghli H, Jahangard L, Holsboer-Trachsler E, Brand S

doi: 10.1007/s00737-017-0753-6.

Anxiety and Depression

Does pre-treatment functioning influence response to intravenous ketamine in adults with treatment-resistant depression?

J Affect Disord

McIntyre RS, Lipsitz O, Lui LMW, Rodrigues NB, Lee Y, Ho RC, Subramaniapillai M, Gill H, Cha DS, Lin K, Teopiz KM, Nasri F, Mansur RB, Kratiuk K, Rosenblat JD

doi: 10.1016/j.jad.2021.05.090

Further Publications Psychiatry

Predictive values of tumor necrosis factor-α for depression treatment outcomes: effect modification by hazardous alcohol consumption

Transl Psychiatry

Choi W, Kang HJ, Kim JW, Kim HK, Kang HC, Lee JY, Kim SW, Stewart R, Kim JM

doi: 10.1038/s41398-021-01581-7

Anxiety and Depression

Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment

Int J Neuropsychopharmacol.

Dold M, Bartova L, Kasper S

doi: 10.1093/ijnp/pyaa034.

Related content

Moderating effect of comorbid anxiety disorders on treatment outcome in a randomized controlled psychotherapy trial in early-onset persistently depressed outpatients

Symptom clusters in adolescent depression and differential response to treatment: a secondary analysis of the Treatment for Adolescents with Depression Study randomised trial

Association of Depression and Treated Depression With Epilepsy and Seizure Outcomes: A Multicohort Analysis

Combining psychopharmacotherapy and psychotherapy is not associated with better treatment outcome in major depressive disorder - evidence from the European Group for the Study of Resistant Depression

High occupational level is associated with poor response to the treatment of depression: A replication study

Influence of adjuvant detached mindfulness and stress management training compared to pharmacologic treatment in primiparae with postpartum depression

Does pre-treatment functioning influence response to intravenous ketamine in adults with treatment-resistant depression?

Predictive values of tumor necrosis factor-α for depression treatment outcomes: effect modification by hazardous alcohol consumption

Treatment Response of Add-On Esketamine Nasal Spray in Resistant Major Depression in Relation to Add-On Second-Generation Antipsychotic Treatment